Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HEREDIA, Alonso")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, ResveratrolHEREDIA, Alonso; DAVIS, Charles; REDFIELD, Robert et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 25, Num 3, pp 246-255, issn 1525-4135Article

Depuración de las aguas de lavado de aceitunas negras mediante procesos biológico aerobio y de ozonización = Purification of black olive washed waters by aerobic biological and ozonation processesBELTRAN DE HEREDIA ALONSO, Jesus; TORREGROSA ANTON, Joaquin; DOMINGUEZ VARGAS, Joaquin R et al.Grasas y aceites (Sevilla). 2001, Vol 52, Num 3-4, pp 184-191, issn 0017-3495Article

Tratamiento con ozono de las aguas residuales de almazara = Ozone treatment of olive mill wastewaterDE HEREDIA ALONSO, Jesus Beltran; TORREGROSA ANTON, Joaquin; GARCIA RODRIGUEZ, Juan et al.Grasas y aceites (Sevilla). 2000, Vol 51, Num 5, pp 301-306, issn 0017-3495Article

Tratamiento biológico aerobio de alpechín depurado previamente con ozono = Aerobic biological treatment of olive mill wastewater previously treated by an ozonation stageDE HEREDIA ALONSO, Jesus Beltran; TORREGROSA ANTON, Joaquin; GARCIA RODRIGUEZ, Jan et al.Grasas y aceites (Sevilla). 2000, Vol 51, Num 5, pp 332-339, issn 0017-3495Article

Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonistsLATINOVIC, Olga; HEREDIA, Alonso; GALLO, Robert C et al.Antiviral research. 2009, Vol 83, Num 1, pp 86-89, issn 0166-3542, 4 p.Article

Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist MaravirocLATINOVIC, Olga; SCHNEIDER, Kate; SZMACINSKI, Henryk et al.Antiviral research. 2014, Vol 112, pp 80-90, issn 0166-3542, 11 p.Article

HIV-1 natural viral suppressors : control of viral replication in the absence of therapySAJADI, Mohammad M; HEREDIA, Alonso; LE, Nhut et al.AIDS (London). 2007, Vol 21, Num 4, pp 517-519, issn 0269-9370, 3 p.Article

An Alteration of Human Immunodeficiency Virus gp41 Leads to Reduced CCR5 Dependence and CD4 IndependenceTAYLOR, Brian M; FOULKE, J. Scott; FLINKO, Robin et al.Journal of virology. 2008, Vol 82, Num 11, pp 5460-5471, issn 0022-538X, 12 p.Article

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionLATINOVIC, Olga; LE, Nhut; REITZ, Marvin et al.AIDS (London). 2011, Vol 25, Num 9, pp 1232-1235, issn 0269-9370, 4 p.Article

Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1HEREDIA, Alonso; DAVIS, Charles; AMIN, Mohammed N et al.AIDS (London). 2014, Vol 28, Num 3, pp 317-323, issn 0269-9370, 7 p.Article

In vitro suppression of latent HIV-1 activation by vitamin E : potential clinical implicationsHEREDIA, Alonso; DAVIS, Charles; AMOROSO, Anthony et al.AIDS (London). 2005, Vol 19, Num 8, pp 836-837, issn 0269-9370, 2 p.Article

Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir Against Sensitive and Drug-Resistant HIV-1HEREDIA, Alonso; DAVIS, Charles E; REITZ, Marvin S et al.The Journal of infectious diseases. 2013, Vol 208, Num 12, pp 2085-2094, issn 0022-1899, 10 p.Article

Resveratrol glucuronides as the metabolites of Resveratrol in humans: Characterization, synthesis, and anti-HIV activityWANG, Lai-Xi; HEREDIA, Alonso; HAIJING SONG et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 10, pp 2448-2457, issn 0022-3549, 10 p.Article

CCR5 density levels on primary CD4 T cells impact the replication and enfuvirtide susceptibility of R5 HIV-1HEREDIA, Alonso; GILLIAM, Bruce; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 10, pp 1317-1322, issn 0269-9370, 6 p.Article

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitroHEREDIA, Alonso; GILLIAM, Bruce; LATINOVIC, Olga et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2489-2496, issn 0066-4804, 8 p.Article

Rapamycin reduces CCR5 mRNA levels in macaques : potential applications in HIV-1 prevention and treatmentGILLIAM, Bruce L; HEREDIA, Alonso; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 15, pp 2108-2110, issn 0269-9370, 3 p.Article

Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replicationHEREDIA, Alonso; DAVIS, Charles; BAMBA, Douty et al.AIDS (London). 2005, Vol 19, Num 18, pp 2087-2095, issn 0269-9370, 9 p.Article

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient managementKOWALSKI, Richard; POST, Diane; REARDON, Elise et al.Clinical transplantation. 2003, Vol 17, Num 2, pp 77-88, issn 0902-0063, 12 p.Article

  • Page / 1